These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 15630726)

  • 41. T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
    Chino Y; Murata H; Goto D; Matsumoto I; Tsutsumi A; Sakamoto T; Ohtsuka M; Sekisawa K; Ito S; Sumida T
    Int J Mol Med; 2006 Jan; 17(1):101-9. PubMed ID: 16328018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis.
    Kameda H; Takeuchi T
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):409-15. PubMed ID: 17214587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary involvement in polymyositis and in dermatomyositis.
    Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
    J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis.
    Won Huh J; Soon Kim D; Keun Lee C; Yoo B; Bum Seo J; Kitaichi M; Colby TV
    Respir Med; 2007 Aug; 101(8):1761-9. PubMed ID: 17428649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
    Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J
    Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.
    Fathi M; Barbasso Helmers S; Lundberg IE
    J Intern Med; 2012 Jun; 271(6):589-97. PubMed ID: 21950266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
    So MW; Koo BS; Kim YG; Lee CK; Yoo B
    J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
    Chen YJ; Wu CY; Shen JL
    Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of interstitial pneumonia of polymyositis-dermatomyositis with various pathological findings in open lung biopsy].
    Mouri M; Nambu Y; Matsui M; Kobayashi Y; Kishimoto N; Noguchi T; Matsuda M; Sakurai S; Ohya N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 May; 31(5):629-35. PubMed ID: 8331851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China.
    Li T; Tang ZY; Zhang QB; Xiao FN; Jian GL; Xie Y; Guo JW; Qing YF
    Curr Rheumatol Rev; 2023; 19(4):455-462. PubMed ID: 37005523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis.
    Hayashi S; Tanaka M; Kobayashi H; Nakazono T; Satoh T; Fukuno Y; Aragane N; Tada Y; Koarada S; Ohta A; Nagasawa K
    J Rheumatol; 2008 Feb; 35(2):260-9. PubMed ID: 18085731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
    Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
    Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis].
    Toyoshima M; Sato A; Chida K; Hayakawa H; Todate A; Imokawa S; Iwata M; Ohashi H; Shirai M; Yagi H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):281-7. PubMed ID: 9168643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
    Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI
    J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.
    Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S
    J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
    Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
    Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.